- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Turmeric supplement effective option for osteoarthritis knee pain: Study
Turmeric is a spice that comes from turmeric plant which is commonly used in Asian food. The turmeric has medicinal value and is used widely as anti inflammatory agent in injuries.Current pharmacologic therapies for patients with osteoarthritis are suboptimal and therefore researchers are always in look out for new therapeutic agents.An extract of Curcuma longa (CL), commonly known as...
Turmeric is a spice that comes from turmeric plant which is commonly used in Asian food. The turmeric has medicinal value and is used widely as anti inflammatory agent in injuries.
Current pharmacologic therapies for patients with osteoarthritis are suboptimal and therefore researchers are always in look out for new therapeutic agents.
An extract of Curcuma longa (CL), commonly known as turmeric, was found to be more effective than placebo for reducing knee pain in patients with knee osteoarthritis. However, CL did not affect structural aspects of knee osteoarthritis, such as swelling or cartilage composition assessed using MRI. Findings from a randomized, double-blind, placebo-controlled trial are published in Annals of Internal Medicine.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751